Fund profile

Zoticon BioVentures

Pre-SeedSeed

Quick facts

HQ Rehovot, Israel

Check size TBD

Founded TBD

Last verified Pending

Type Venture Capital

Website TBD

Apply TBD

Stage focus Pre-Seed, Seed

Sector focus TBD

Zoticon has invested over $100 million to date in promising phase III therapeutics including two oncology products and a cardiovascular

BiotechPharmaceutical

For founders

Answer a few focused questions and get a sharper starting list of Israeli and Israel-relevant funds to approach next.

Useful when you want to compare this fund against others that match your round, category, and Israel connection.